Published in Br J Cancer on August 08, 2005
Reporting methods in studies developing prognostic models in cancer: a review. BMC Med (2010) 1.68
Reporting performance of prognostic models in cancer: a review. BMC Med (2010) 1.65
A large cohort study reveals the association of elevated peripheral blood lymphocyte-to-monocyte ratio with favorable prognosis in nasopharyngeal carcinoma. PLoS One (2013) 1.50
The ratio of the absolute lymphocyte count to the absolute monocyte count is associated with prognosis in Hodgkin's lymphoma: correlation with tumor-associated macrophages. Oncologist (2012) 1.41
Do the derived neutrophil to lymphocyte ratio and the neutrophil to lymphocyte ratio predict prognosis in breast cancer? Int J Clin Oncol (2014) 1.27
Monocyte subset dynamics in human atherosclerosis can be profiled with magnetic nano-sensors. PLoS One (2009) 1.20
Protumor and antitumor functions of neutrophil granulocytes. Semin Immunopathol (2012) 1.17
The Peripheral Blood Neutrophil-To-Lymphocyte Ratio Is Superior to the Lymphocyte-To-Monocyte Ratio for Predicting the Long-Term Survival of Triple-Negative Breast Cancer Patients. PLoS One (2015) 1.07
Baseline elevated leukocyte count in peripheral blood is associated with poor survival in patients with advanced non-small cell lung cancer: a prognostic model. J Cancer Res Clin Oncol (2008) 1.07
The prognostic value of tumor-infiltrating neutrophils in gastric adenocarcinoma after resection. PLoS One (2012) 1.06
An elevated peripheral blood lymphocyte-to-monocyte ratio predicts favorable response and prognosis in locally advanced breast cancer following neoadjuvant chemotherapy. PLoS One (2014) 1.01
Effects of gender on white blood cell populations and neutrophil-lymphocyte ratio following gastrectomy in patients with stomach cancer. J Korean Med Sci (2007) 0.99
Blood neutrophil-lymphocyte ratio predicts survival for stages III-IV gastric cancer treated with neoadjuvant chemotherapy. World J Surg Oncol (2013) 0.99
The activation pattern of blood leukocytes in head and neck squamous cell carcinoma is correlated to survival. PLoS One (2012) 0.98
Low preoperative lymphocyte to monocyte ratio predicts poor cancer-specific survival in patients with esophageal squamous cell carcinoma. Onco Targets Ther (2015) 0.98
Blood neutrophil-to-lymphocyte ratio is prognostic in gastrointestinal stromal tumor. Ann Surg Oncol (2012) 0.97
The neutrophil-lymphocyte ratio and its utilisation for the management of cancer patients in early clinical trials. Br J Cancer (2015) 0.96
Immunotherapy of distant metastatic disease. Ann Oncol (2009) 0.96
Tumor-induced myeloid dysfunction and its implications for cancer immunotherapy. Cancer Immunol Immunother (2014) 0.94
Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients. World J Gastroenterol (2015) 0.93
Elevated peripheral blood lymphocyte-to-monocyte ratio predicts a favorable prognosis in the patients with metastatic nasopharyngeal carcinoma. Chin J Cancer (2015) 0.93
Neutrophil-to-lymphocyte ratio may be associated with the outcome in patients with prostate cancer. Springerplus (2015) 0.93
A nomogram to predict prognostic values of various inflammatory biomarkers in patients with esophageal squamous cell carcinoma. Am J Cancer Res (2015) 0.93
Prognostic significance of peripheral monocyte count in patients with extranodal natural killer/T-cell lymphoma. BMC Cancer (2013) 0.92
Prognostic impact of platelet/lymphocyte and neutrophil/lymphocyte ratios in patients with gastric cancer: a multicenter study. Int J Clin Exp Med (2015) 0.92
Cancer-associated myeloproliferation: old association, new therapeutic target. Mayo Clin Proc (2010) 0.90
Neutrophils in Cancer: Two Sides of the Same Coin. J Immunol Res (2015) 0.90
A Low Lymphocyte-to-Monocyte Ratio Predicts Unfavorable Prognosis in Pathological T3N0 Rectal Cancer Patients Following Total Mesorectal Excision. J Cancer (2015) 0.90
Peripheral blood lymphocyte/monocyte ratio at the time of first relapse predicts outcome for patients with relapsed or primary refractory diffuse large B-cell lymphoma. BMC Cancer (2014) 0.89
Promoting effect of neutrophils on lung tumorigenesis is mediated by CXCR2 and neutrophil elastase. Mol Cancer (2013) 0.89
Pre-treatment neutrophil to lymphocyte ratio may be a useful tool in predicting survival in early triple negative breast cancer patients. BMC Cancer (2015) 0.88
CD16+ monocytes in breast cancer patients: expanded by monocyte chemoattractant protein-1 and may be useful for early diagnosis. Clin Exp Immunol (2011) 0.87
Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Localized and Advanced Prostate Cancer: A Systematic Review and Meta-Analysis. PLoS One (2016) 0.86
The prognostic role of the preoperative absolute lymphocyte count and absolute monocyte count in patients with resected advanced melanoma. Am J Clin Oncol (2015) 0.85
Elevated preoperative peripheral blood monocyte count predicts poor prognosis for hepatocellular carcinoma after curative resection. BMC Cancer (2014) 0.84
Glioblastoma-infiltrated innate immune cells resemble M0 macrophage phenotype. JCI Insight (2016) 0.83
Prognostic Significance of Preoperative Circulating Monocyte Count in Patients With Breast Cancer: Based on a Large Cohort Study. Medicine (Baltimore) (2015) 0.82
The prognostic impact of preoperative blood monocyte count in pathological T3N0M0 rectal cancer without neoadjuvant chemoradiotherapy. Tumour Biol (2015) 0.81
Surrogacy of tumor response and progression-free survival for overall survival in metastatic breast cancer resistant to both anthracyclines and taxanes. Int J Clin Oncol (2011) 0.80
The Response of Macrophages and Neutrophils to Hypoxia in the Context of Cancer and Other Inflammatory Diseases. Mediators Inflamm (2016) 0.77
Phorbol ester-induced neutrophilic inflammatory responses selectively promote metastatic spread of melanoma in a TLR4-dependent manner. Oncoimmunology (2015) 0.77
Gradient Infiltration of Neutrophil Extracellular Traps in Colon Cancer and Evidence for Their Involvement in Tumour Growth. PLoS One (2016) 0.77
Albumin and Neutrophil Combined Prognostic Grade as a New Prognostic Factor in Non-Small Cell Lung Cancer: Results from a Large Consecutive Cohort. PLoS One (2015) 0.75
Control of immune cell entry through the tumour vasculature: a missing link in optimising melanoma immunotherapy? Clin Transl Immunology (2017) 0.75
Preoperative Aspartate Aminotransferase to White Blood Cell Count Ratio Predicting Postoperative Outcomes of Hepatocellular Carcinoma. Medicine (Baltimore) (2016) 0.75
Prognostic value of inflammation-based scores in patients with osteosarcoma. Sci Rep (2016) 0.75
Monitoring of the Immune Dysfunction in Cancer Patients. Vaccines (Basel) (2016) 0.75
Derived neutrophil to lymphocyte ratio predicts prognosis for patients with HBV-associated hepatocellular carcinoma following transarterial chemoembolization. Oncol Lett (2016) 0.75
Systemic Immune-Inflammation Index and Circulating T-Cell Immune Index Predict Outcomes in High-Risk Acral Melanoma Patients Treated with High-Dose Interferon. Transl Oncol (2017) 0.75
Prognostic role of neutrophil lymphocyte ratio in patients with glioma. Oncotarget (2017) 0.75
Fractional laser exposure induces neutrophil infiltration (N1 phenotype) into the tumor and stimulates systemic anti-tumor immune response. PLoS One (2017) 0.75
The hallmarks of cancer. Cell (2000) 113.05
Inflammation and cancer. Nature (2002) 53.78
Inflammation and cancer: back to Virchow? Lancet (2001) 27.40
Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer (2004) 14.55
Cancer and the chemokine network. Nat Rev Cancer (2004) 10.27
Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol (2001) 10.20
Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol (2001) 9.68
What do we mean by validating a prognostic model? Stat Med (2000) 9.18
Prognostic factors in 1,521 melanoma patients with distant metastases. J Am Coll Surg (1995) 4.37
Durability of complete responses in patients with metastatic cancer treated with high-dose interleukin-2: identification of the antigens mediating response. Ann Surg (1998) 4.35
High-dose recombinant interleukin-2 therapy in patients with metastatic melanoma: long-term survival update. Cancer J Sci Am (2000) 4.19
Prognostic factors in metastatic melanoma: a pooled analysis of Eastern Cooperative Oncology Group trials. J Clin Oncol (2000) 2.86
Metastatic renal carcinoma comprehensive prognostic system. Br J Cancer (2003) 2.18
Role of CXCL1 in tumorigenesis of melanoma. J Leukoc Biol (2002) 2.13
Prognostic factors of survival and rapid progression in 782 patients with metastatic renal carcinomas treated by cytokines: a report from the Groupe Français d'Immunothérapie. Ann Oncol (2002) 2.03
Role of infiltrated leucocytes in tumour growth and spread. Br J Cancer (2004) 1.98
Activation of progelatinase A (MMP-2) by neutrophil elastase, cathepsin G, and proteinase-3: a role for inflammatory cells in tumor invasion and angiogenesis. J Cell Physiol (2001) 1.88
Expression and growth-promoting function of the IL-8 receptor beta in human melanoma cells. J Immunol (1996) 1.86
Differential response of primary and metastatic melanomas to neutrophils attracted by IL-8. Int J Cancer (2003) 1.62
Prognostic factors in patients with metastatic malignant melanoma. A multivariate analysis. Cancer (1993) 1.52
The tumorigenic and angiogenic effects of MGSA/GRO proteins in melanoma. J Leukoc Biol (2000) 1.48
Results of interleukin-2-based treatment in advanced melanoma: a case record-based analysis of 631 patients. J Clin Oncol (1998) 1.46
Expression of transcripts for two interleukin 8 receptors in human phagocytes, lymphocytes and melanoma cells. Biochem J (1993) 1.32
Prognostic factors for survival of patients treated systemically for disseminated melanoma. J Clin Oncol (1998) 1.29
Serum interleukin-8 (IL-8) is elevated in patients with metastatic melanoma and correlates with tumour load. Melanoma Res (1995) 1.28
Leukocyte orchestration in blood and tumour tissue following interleukin-2 based immunotherapy in metastatic renal cell carcinoma. Cancer Immunol Immunother (2004) 1.12
A phase II study of outpatient subcutaneous histamine dihydrochloride, interleukin-2 and interferon-alpha in patients with metastatic melanoma. Ann Oncol (2002) 0.86
Subcutaneous interleukin-2 and interferon-alpha plus cisplatin with and without prophylactic cimetidine in patients with metastatic malignant melanoma: a phase II study. Melanoma Res (2000) 0.79
A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry (1983) 6.38
A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection. The Syphilis and HIV Study Group. N Engl J Med (1997) 4.11
Radiotherapy versus single-dose carboplatin in adjuvant treatment of stage I seminoma: a randomised trial. Lancet (2005) 3.75
High-efficiency gene transfer into skeletal muscle mediated by electric pulses. Proc Natl Acad Sci U S A (1999) 3.31
European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG). Ann Oncol (2004) 2.65
Prevalence and causes of albuminuria in non-insulin-dependent diabetic patients. Kidney Int (1992) 2.51
Association of perceived physician communication style with patient satisfaction, distress, cancer-related self-efficacy, and perceived control over the disease. Br J Cancer (2003) 2.47
Duodenal adenomatosis in familial adenomatous polyposis. Gut (2004) 2.38
Standardization of high-resolution flow cytometric DNA analysis by the simultaneous use of chicken and trout red blood cells as internal reference standards. Cytometry (1983) 2.32
Automation of sample mounting for macromolecular crystallography. Acta Crystallogr D Biol Crystallogr (2006) 2.22
A transmissible feline fibrosarcoma of viral origin. Cancer Res (1971) 2.17
The response of symptomatic neurosyphilis to high-dose intravenous penicillin G in patients with human immunodeficiency virus infection. N Engl J Med (1994) 2.08
A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5-85. Radiother Oncol (1998) 2.07
Syphilis-associated perinatal and infant mortality in rural Malawi. Bull World Health Organ (1993) 1.96
High levels of urokinase-type plasminogen activator and its inhibitor PAI-1 in cytosolic extracts of breast carcinomas are associated with poor prognosis. Cancer Res (1993) 1.86
Independent prognostic value of eosinophil and mast cell infiltration in colorectal cancer tissue. J Pathol (1999) 1.86
Causes of albuminuria in patients with type 2 diabetes without diabetic retinopathy. Kidney Int (2000) 1.85
Risk of recurrence 5 years or more after primary Lichtenstein mesh and sutured inguinal hernia repair. Br J Surg (2007) 1.82
A review of techniques and results obtained in one laboratory by an integrated system of methods designed for routine clinical flow cytometric DNA analysis. Cytometry (1990) 1.68
Structural basis for the catalytic mechanism of a proficient enzyme: orotidine 5'-monophosphate decarboxylase. Biochemistry (2000) 1.67
Factors influencing the sample size, exemplified by studies on gastroduodenal tolerability of drugs. Scand J Gastroenterol (1985) 1.67
Growth of colorectal polyps: recovery and evaluation of unresected polyps of less than 10 mm, 1 year after detection. Scand J Gastroenterol (1994) 1.66
Cervical lymph node metastases from unknown primary tumours. Results from a national survey by the Danish Society for Head and Neck Oncology. Radiother Oncol (2000) 1.64
Plasma urokinase receptor levels in patients with colorectal cancer: relationship to prognosis. J Natl Cancer Inst (1999) 1.64
Double-blind, placebo-controlled trial of the pain-relieving effects of the implantation of gold beads into dogs with hip dysplasia. Vet Rec (2006) 1.63
Recurrence and survival after mesorectal excision for rectal cancer. Br J Surg (2003) 1.61
Preoperative plasma plasminogen activator inhibitor type-1 and serum C-reactive protein levels in patients with colorectal cancer. The RANX05 Colorectal Cancer Study Group. Ann Surg Oncol (2000) 1.58
Serum YKL-40 and colorectal cancer. Br J Cancer (1999) 1.57
Limits of detection of nuclear DNA abnormalities by flow cytometric DNA analysis. Results obtained by a set of methods for sample-storage, staining and internal standardization. Cytometry (1983) 1.56
Treatment of the restless legs syndrome with carbamazepine: a double blind study. Br Med J (Clin Res Ed) (1984) 1.56
Rhamnogalacturonan acetylesterase elucidates the structure and function of a new family of hydrolases. Structure (2000) 1.54
Blood lead-blood pressure relations: alcohol intake and hemoglobin as confounders. Am J Epidemiol (1989) 1.53
High-throughput sample handling and data collection at synchrotrons: embedding the ESRF into the high-throughput gene-to-structure pipeline. Acta Crystallogr D Biol Crystallogr (2006) 1.50
Growth of colorectal polyps: redetection and evaluation of unresected polyps for a period of three years. Gut (1996) 1.50
Soluble vascular endothelial growth factor levels in patients with primary colorectal carcinoma. The Danish RANX05 Colorectal Cancer Study Group. Eur J Surg Oncol (2000) 1.48
Association between high concentrations of Mr 52,000 cathepsin D and poor prognosis in primary human breast cancer. Cancer Res (1989) 1.48
Lactational competence and involution of the mouse mammary gland require plasminogen. Development (2000) 1.48
Effects of the combination of blood transfusion and postoperative infectious complications on prognosis after surgery for colorectal cancer. Danish RANX05 Colorectal Cancer Study Group. Br J Surg (2000) 1.47
Prognostic impact of matched preoperative plasma and serum VEGF in patients with primary colorectal carcinoma. Br J Cancer (2002) 1.47
Bolus i.v. nitroglycerin treatment of ischemic chest pain in the ED. Am J Emerg Med (1994) 1.46
Primary evaluation of patients suspected of having interstitial cystitis (IC). Eur Urol (2004) 1.46
Structural basis for the function of Bacillus subtilis phosphoribosyl-pyrophosphate synthetase. Nat Struct Biol (2000) 1.43
Traffic-related air pollution: exposure and health effects in Copenhagen street cleaners and cemetery workers. Arch Environ Health (1995) 1.42
Ranitidine as adjuvant treatment in colorectal cancer. Br J Surg (2002) 1.41
Pattern of metastases in relation to characteristics of primary tumor and treatment in patients with disseminated urothelial carcinoma. J Urol (1996) 1.39
Efficiency of high- and low-voltage pulse combinations for gene electrotransfer in muscle, liver, tumor, and skin. Hum Gene Ther (2008) 1.39
Intrapartum death of nonmalformed fetuses in Denmark and Sweden in 1991. A perinatal audit. Acta Obstet Gynecol Scand (1997) 1.38
[Potentially avoidable perinatal deaths in Denmark and Sweden 1991]. Ugeskr Laeger (1997) 1.38
Long-term storage of samples for flow cytometric DNA analysis. Cytometry (1983) 1.36
Short term outcome after emergency and elective surgery for colon cancer. Colorectal Dis (2008) 1.35
Passive transfer of antiviral antibodies restricts replication of Aleutian mink disease parvovirus in vivo. J Virol (1989) 1.32
The X-ray crystal structure of beta-ketoacyl [acyl carrier protein] synthase I. FEBS Lett (1999) 1.31
Cysteine proteinase inhibitors stefin A, stefin B, and cystatin C in sera from patients with colorectal cancer: relation to prognosis. Clin Cancer Res (2000) 1.31
Studies of the choledocho-duodenal sphincter in patients with and without juxta-papillary duodenal diverticula. Scand J Gastroenterol (1980) 1.29
Hostility, incidence of acute myocardial infarction, and mortality in a sample of older Danish men and women. Am J Epidemiol (1995) 1.28
A precise and efficient stereological method for determining murine lung metastasis volumes. Am J Pathol (2001) 1.28
High preoperative plasma tissue inhibitor of metalloproteinase-1 levels are associated with short survival of patients with colorectal cancer. Clin Cancer Res (2000) 1.27
Thiazide prophylaxis of urolithiasis. A double-blind study in general practice. Acta Med Scand (1984) 1.26
Duodenal diverticula and their relationship to age, sex, and biliary calculi. Scand J Gastroenterol (1981) 1.26
The Glostrup population studies. Collection of epidemiologic tables. Reference values for use in cardiovascular population studies. Scand J Soc Med Suppl (1981) 1.26
Osteoradionecrosis of the jaws: clinical characteristics and relation to the field of irradiation. J Oral Maxillofac Surg (2000) 1.24
The crystal structure of Lactococcus lactis dihydroorotate dehydrogenase A complexed with the enzyme reaction product throws light on its enzymatic function. Protein Sci (1998) 1.24
Quantitation of TIMP-1 in plasma of healthy blood donors and patients with advanced cancer. Br J Cancer (1999) 1.24
Tissue inhibitor of metalloproteinases-1 in breast cancer. Endocr Relat Cancer (2005) 1.24
Some aspects of the structure of staphylococcal nuclease. I. Crystallographic studies. Cold Spring Harb Symp Quant Biol (1972) 1.23
Syncytin is involved in breast cancer-endothelial cell fusions. Cell Mol Life Sci (2006) 1.22
The crystal structure of the flavin containing enzyme dihydroorotate dehydrogenase A from Lactococcus lactis. Structure (1997) 1.22
Analysis of experimental mink enteritis virus infection in mink: in situ hybridization, serology, and histopathology. J Virol (1990) 1.22
Nebulised beclomethasone dipropionate in recurrent obstructive episodes after acute bronchiolitis. Arch Dis Child (1988) 1.21
In situ measurement of colorectal polyps to compare video and fiberoptic endoscopes. Endoscopy (1994) 1.21
The epidemiology and prognosis of glomerulonephritis in Denmark 1985-1997. Nephrol Dial Transplant (1999) 1.19
Active site of dihydroorotate dehydrogenase A from Lactococcus lactis investigated by chemical modification and mutagenesis. Biochemistry (1997) 1.19
Postural load during VDU work: a comparison between various work postures. Ergonomics (1997) 1.18
Postoperative medical complications are the main cause of early death after emergency surgery for colonic cancer. Br J Surg (2008) 1.18
Surgery and radiotherapy in the treatment of cutaneous melanoma. Ann Oncol (2009) 1.18
Detergent and proteolytic enzyme-based techniques for nuclear isolation and DNA content analysis. Methods Cell Biol (1994) 1.17
Carcinoma in situ of contralateral testis in patients with testicular germ cell cancer: study of 27 cases in 500 patients. Br Med J (Clin Res Ed) (1986) 1.15
Epidemiology of polyps in the rectum and colon. Recovery and evaluation of unresected polyps 2 years after detection. Scand J Gastroenterol (1986) 1.15
The crystal structure of rhamnogalacturonase A from Aspergillus aculeatus: a right-handed parallel beta helix. Structure (1997) 1.14
The pathophysiology of diabetes involves a defective amplification of the late-phase insulin response to glucose by glucose-dependent insulinotropic polypeptide-regardless of etiology and phenotype. J Clin Endocrinol Metab (2003) 1.13
Influence of a supplemental carbon source on anaerobic dechlorination of pentachlorophenol in granular sludge. Appl Environ Microbiol (1992) 1.12
Carcinoma in situ of the female breast. 10 year follow-up results of a prospective nationwide study. Breast Cancer Res Treat (2000) 1.12
Electrochemotherapy: technological advancements for efficient electroporation-based treatment of internal tumors. Med Biol Eng Comput (2012) 1.11
Acute interstitial pneumonia in mink kits inoculated with defined isolates of Aleutian mink disease parvovirus. Vet Pathol (1994) 1.11
Acute interstitial pneumonitis caused by Aleutian disease virus in mink kits. Acta Pathol Microbiol Immunol Scand A (1984) 1.11
Treatment outcome following radiotherapy in elderly patients with bladder cancer. Radiother Oncol (1997) 1.10
Influence of late side-effects upon daily life after radiotherapy for laryngeal and pharyngeal cancer. Acta Oncol (1994) 1.10
Validation of the PHEEM instrument in a Danish hospital setting. Med Teach (2007) 1.10
Carcinoma in situ of testicular tissue adjacent to malignant germ-cell tumors: a study of 105 cases. Cancer (1981) 1.09
Importance of association between permeabilization and electrophoretic forces for intramuscular DNA electrotransfer. Biochim Biophys Acta (2000) 1.08
Infections with Neisseria gonorrhoeae and Chlamydia trachomatis in women with acute salpingitis. Genitourin Med (1985) 1.08
Small molecules and targeted therapies in distant metastatic disease. Ann Oncol (2009) 1.08
Deficiency of mannan-binding lectin associated serine protease-2 due to missense polymorphisms. Genes Immun (2007) 1.08
Determination of vascular endothelial growth factor (VEGF) in circulating blood: significance of VEGF in various leucocytes and platelets. Scand J Clin Lab Invest (2002) 1.07
Clinical radiobiology of malignant melanoma. Radiother Oncol (1989) 1.07
DNA ploidy-characteristics of human malignant melanoma analysed by flow cytometry and compared with histology and clinical course. Virchows Arch B Cell Pathol Incl Mol Pathol (1983) 1.07
Low level laser versus placebo in the treatment of tennis elbow. Scand J Rehabil Med (1992) 1.07
Structures of beta-ketoacyl-acyl carrier protein synthase I complexed with fatty acids elucidate its catalytic machinery. Structure (2001) 1.06
Effect of diclofenac and naproxen on gastroduodenal mucosa. Clin Pharmacol Ther (1979) 1.06